Bowel Preparations for Colonoscopy: an RCT
Overview
Authors
Affiliations
Background: The ideal preparation regimen for pediatric colonoscopy remains elusive, and available preparations continue to represent a challenge for children. The aim of this study was to compare the efficacy, safety, tolerability, and acceptance of 4 methods of bowel cleansing before colonoscopy in children.
Methods: This randomized, investigator-blinded, noninferiority trial enrolled all children aged 2 to 18 years undergoing elective colonoscopy in a referral center for pediatric gastroenterology. Patients were randomly assigned to receive polyethylene glycol (PEG) 4000 with simethicon (PEG-ELS group) or PEG-4000 with citrates and simethicone plus bisacodyl (PEG-CS+Bisacodyl group), or PEG 3350 with ascorbic acid (PEG-Asc group), or sodium picosulfate plus magnesium oxide and citric acid (NaPico+MgCit group). Bowel cleansing was evaluated according to the Boston Bowel Preparation Scale. The primary end point was overall colon cleansing. Tolerability, acceptability, and compliance were also evaluated.
Results: Two hundred ninety-nine patients were randomly allocated to the 4 groups. In the per-protocol analysis, PEG-CS+Bisacodyl, PEG-Asc, and NaPico+MgCit were noninferior to PEG-ELS in bowel-cleansing efficacy of both the whole colon (P = .910) and colonic segments. No serious adverse events occurred in any group. Rates of tolerability, acceptability, and compliance were significantly higher in the NaPico+MgCit group.
Conclusions: Low-volume PEG preparations (PEG-CS+Bisacodyl, PEG-Asc) and NaPico+MgCit are noninferior to PEG-ELS in children, representing an attractive alternative to high-volume regimens in clinical practice. Because of the higher tolerability and acceptability profile, NaPico+MgCit would appear as the most suitable regimen for bowel preparation in children.
Using the Cardiac-Electrophysiological Balance Index to Predict Arrhythmia Risk After Colonoscopy.
Polatkan S, Gunay-Polatkan S, Isik O, Sigirli D Medicina (Kaunas). 2025; 61(1).
PMID: 39858995 PMC: 11766922. DOI: 10.3390/medicina61010013.
Furio S, Lucarini A, Mennini M, Strisciuglio C, Felici E, Ferretti A J Pediatr Gastroenterol Nutr. 2024; 80(1):25-33.
PMID: 39400405 PMC: 11717393. DOI: 10.1002/jpn3.12388.
A syrup containing L-arabinose and D-xylose appears superior to PEG-4000 as a bowel cleansing agent.
Wang D, Liao X, Zhang H, Wang Y, Zhang M, Ren F AMB Express. 2024; 14(1):63.
PMID: 38824272 PMC: 11144180. DOI: 10.1186/s13568-024-01715-2.
Russo G, Alvisi P, Romano C, Angelino G, Lemale J, Lachaux A Endosc Int Open. 2024; 12(4):E629-E638.
PMID: 38681144 PMC: 11052644. DOI: 10.1055/a-2251-3372.
Dziechciarz P, Ruszczynski M, Horvath A Pediatr Gastroenterol Hepatol Nutr. 2022; 25(3):228-239.
PMID: 35611374 PMC: 9110845. DOI: 10.5223/pghn.2022.25.3.228.